Spain Biomaterials in Healthcare Market Report 2022 to 2030

Spain Biomaterials in Healthcare Market Analysis

$ 3999

The Spain Biomaterials Healthcare Market is expected to witness growth from $3.01 Bn in 2022 to $7.57 Bn in 2030 with a CAGR of 12.20% for the forecasted year 2022-2030. In Spain, Biomaterials are used in the developing area of regenerative medicine to repair or replace diseased or damaged tissues and organs. This is fuelling demand for biomaterials in Spain's healthcare market. The market is segmented by type and by application. Some key players in this market include Bioiberica, Regemat, Quimatryx, BASF SE, Celanese, Covestro AG and Evonik Industries.

ID: IN10ESMD003 CATEGORY: Medical Devices GEOGRAPHY: Spain AUTHOR: Jigyasu Bhandari

Buy Now

Spain Biomaterials in Healthcare Market Executive Analysis

The Spain Biomaterials Healthcare Market size is at around $3.01 Bn in 2022 and is projected to reach $7.57 Bn in 2030, exhibiting a CAGR of 12.20% during the forecast period. Less than 3% of all government spending goes to the Spanish Minister of Health. The Ministry of Health's budget rise by 6.5% in 2023 to a total of $3308,34 Mn. The national network for public health surveillance will receive $4.48 Mn, and Spain's new National Public Health Agency receive $3.41 Mn.

In Spain, the use of biomaterials is primarily used in the fields of orthopaedics, cardiovascular, dentistry, and wound treatment. With a market share of more than 40%, the orthopaedics sector is the largest. In the biomaterials industry, Spain has a strong emphasis on research and development, with numerous universities and research organisations undertaking ground-breaking work in this area. For instance, the University of the Basque Country's Biomaterials and Bioengineering Laboratory is a renowned study facility in Spain. To better integrate with the body, biomaterials are created to imitate the characteristics of natural tissues and organs. Better patient outcomes, such as quicker healing periods, fewer complications, and higher quality of life, may result from this. Costs of long-term care and treatment can be decreased with the use of biomaterials in healthcare. Biomaterials have the potential to help patients and healthcare practitioners save money by lowering the need for additional procedures or interventions. Patients who previously might not have had access to particular treatments or medicines may benefit from increased access to care thanks in part to biomaterials. Biomaterials can help to improve health outcomes for a broader variety of patients by offering more treatment options.

Spain Biomaterials Healthcare Market Analysis

Market Dynamics

Market Growth Drivers

In Spain, Biomaterials are used in the developing area of regenerative medicine to repair or replace diseased or damaged tissues and organs. This is fuelling demand for biomaterials in Spain's healthcare market. Cancer and cardiovascular illness are becoming more common in Spain. The industry is expanding as a result of the development and use of biomaterials to treat these diseases. With an increasing proportion of citizens over 65, Spain has an ageing populace. The market is expanding as a result of the use of biomaterials to address age-related diseases like osteoporosis and arthritis. Advances in biomaterials technology in Spain are expanding the range of biomaterials that can be created and applied for medical uses. As a consequence, innovation and development are driving the market for healthcare biomaterials.

Market Restraints

For Spanish startups and small businesses in particular, the development and testing of biomaterials can be expensive. Due to this, it might be challenging for manufacturers to enter the Spanish healthcare industry or to outbid older, more reputable rivals. Conventional surgical implants, drug treatments, and other well-established medical technologies compete with biomaterials in the medical field. There might be less demand for biomaterials if consumers and healthcare professionals favour these technologies.

Competitive Landscape

Key Players

Bioiberica (ES)
Regemat (ES)
Quimatryx (ES)
BASF SE
Celanese
Covestro AG
Evonik Industries

Notable Recent Deals

2021: To create and sell hyaluronic acid-based biomaterials for inflammatory and respiratory diseases, Bioiberica partnered with the Italian pharmaceutical firm Chiesi in 2021.

Healthcare Policies and Regulatory Landscape

The Medical Devices Regulation of the European Union, which mandates that manufacturers prove their devices are safe and effective before they can be sold in Spain, applies to biomaterials used in medical applications. The EU Clinical Trials Regulation, which lays out guidelines for the design, execution, and reporting of clinical trials of medical products, must be followed when conducting clinical trials of biomaterials in Spain. Health technology assessments are conducted on the biomaterials used in Spain's state healthcare system to determine the clinical and financial merits of various medical procedures and technologies. Spanish Agency for Medicines and Medical Devices is in charge of overseeing the licencing and monitoring of biomaterials for medical uses, as well as the regulation of medical devices and pharmaceuticals in Spain.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Spain market in 2019. The growing geriatric population Spainly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.